mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.03 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.03 |
mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.04 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.04 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.04 |
mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.04 |
mRNA |
MK-0752 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.04 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.04 |
mRNA |
BRD-K02492147 |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.04 |
mRNA |
BRD-K20514654 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.04 |